Research 60–80% of participants continued with clinically significant reductions in depression or anxiety -NYU clinical trial for depression & anxiety 80% of participants continuing to show clinically significant decreases in depressed mood and anxiety -Johns Hopkins clinical trial for depression & anxiety Johns Hopkins researchers report 15 study participants taking psilocybin achieved an 80 percent abstinence rate-Johns Hopkins clinical trial for smoking cessation
